Beagle 20logo 20for 20linkedin
B 20logo 20symbol

Beagle Bioproducts, Inc.

Beagle Bioproducts has an exciting new innovation at the intersection of anti-aging and suncare, positioning shareholders to participate in a strategic exit.

  • Stage Prototype Ready
  • Industry Consumer Products
  • Location Columbus, OH, USA
  • Currency USD
  • Founded January 2012
  • Employees 5
  • Website

Company Summary

Beagle was founded in 2012 to be a specialty biochemical company that extracted natural products from toxic blue-green algae. Our first products have included toxins and pigments, sold through our online store. Our patent-pending extraction process led us to the development of PhycoPro, a proprietary ingredient that contains natural compounds that absorb UVA rays. Our aim is to launch Cyantific Skin Care, with anti-aging and suncare products.


  • Default avatar
    Eric P Roy

    Mr. Roy is an experienced finance professional and serves as Beagle's CEO/CFO, having helped lead a successful $90+ million IPO for Airnet Systems, as well as working in corporate development and finance for many early-stage companies in the Columbus area. He is an active angel investor, and has been involved with the Ohio TechAngels since they were founded in 2004. He is the architect of Beagle's offering and also manages day-to-day finances.

  • Default avatar
    Stephanie A Smith

    Dr. Smith serves as Beagle's COO/CSO, having her PhD in Microbiology from The Ohio State University, with leadership experience as a Senior Scientist at Battelle Memorial Institute and as the Chief Scientist at Algaeventure Systems. She is a recognized expert in toxic algae, and developed the patented process that has led to the development of the PhycoPro ingredient. She now oversees the technical development of Cyantific Skin Care.


  • Default avatar
    Dr. Konstantinos Lahanas
    Cosmetic Chemist
    Default avatar
    Mr. John Tedeschitede
    Quality & Regulatory Strategy

Previous Investors

  • Default avatar
    We have ~30, names are confidential